Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
<p>Abstract</p> <p>The rapid antibiotic resistance development has created a major demand for new antimicrobial agents that can combat resistant strains such as methicillin-resistant <it>S. aureus </it>(MRSA). Until a short time ago, the glycopeptide vancomycin was the only therapeutic choice in thi...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2010-11-01
|
| Col·lecció: | European Journal of Medical Research |
| Accés en línia: | http://www.eurjmedres.com/content/15/12/533 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|